Efficacy and Safety Evaluation of Intrathecal Pemetrexed in EGFR-mutated NSCLC Patients 
with Leptomeningeal Metastases

Background and objective The incidence of leptomeningeal metastasis (LM) in patients with advanced non-small cell lung cancer (NSCLC) is increasing gradually. However, it poses therapeutic challenges due to limited effective interventions. Intrathecal Pemetrexed (IP) holds broad application prospect...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Tianli ZHANG, Xin CHEN, Cheng JIANG, Yongjuan LIN, Yu XIE, Huiying LI, Zhenyu YIN, Tingting YU
Formato:	Artigo
Idioma:	Chinês
Publicado em:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2025-08-01
coleção:	Chinese Journal of Lung Cancer
Assuntos:	lung neoplasms leptomeningeal metastasis epidermal growth factor receptor intrathecal chemotherapy pemetrexed
Acesso em linha:	http://dx.doi.org/10.3779/j.issn.1009-3419.2025.106.23
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!